Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-114.80%
↓ 202% below average
Average (9y)
112.18%
Historical baseline
Range
High:678.30%
Low:-114.80%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -114.80% |
| 2023 | 8.33% |
| 2022 | 42.68% |
| 2021 | -12.93% |
| 2020 | 127.95% |
| 2019 | -44.48% |
| 2018 | 678.30% |
| 2017 | 330.43% |
| 2016 | 80.17% |
| 2015 | 26.11% |